Exelixis Inc. News
Aging Bull: Cramer's 'Mad Money' Recap (Thursday 4/30/20)
Jim Cramer asks how many job losses it takes to stop an aging, raging bull. We may have found out.
Kidney Cancer Drug From Bristol-Myers and Exelixis Meets Key Phase III Endpoint
A kidney-cancer drug candidate combining treatments from Bristol-Myers and Exelixis met its primary endpoint of progression-free survival, the companies said. Exelixis shares jumped on the report.
Be Prepared: Cramer's 'Mad Money' Recap (Monday 12/9/19)
The U.S. economy is rolling along, but there are still a couple of headline risks to watch out for, Jim Cramer says.
Can't Keep the Winners Down: Cramer's 'Mad Money' Recap
Jim Cramer says that sometimes it takes a really bad day to reveal the true winning stocks.
Cisco Systems, Sunrun, Zebra Technologies: 'Mad Money' Lightning Round
Jim Cramer weighs in on Cisco Systems, Sunrun, Zebra Technologies, EQT Midstream Partners, Exelixis, The Trade Deck and more.
Fitbit, Moderna, Tilray: 'Mad Money' Lightning Round
Jim Cramer takes a closer look at Fitbit, Moderna, Tilray, Exelixis, Maxar Technology, International Paper and more.
Exelixis Rises as Fourth-Quarter Earnings Beat Estimates
The company reports fourth-quarter earnings above analysts' forecasts amid strong revenue from collaboration agreements and royalty payments to distribute its drugs.
Breaking Down Citigroup Earnings: Cramer's 'Mad Money' Recap
We may be so worried about the state of the global economy that we're missing some great opportunities, Jim Cramer says.
Bally's Close to Making a Huge Las Vegas Strip Deal
The casino operator does not own the casino that carries its name, but changes are in the works.
New Coca-Cola Flavor is So Hip, It Comes With Its Own QR Code
Beverage giant is rolling out a new taste in its efforts to attract and keep a key demographic.
You'll Almost Have to Buy an Electric Vehicle if Climate Bill Passes
You can find savings on everything from EVs to solar panels in the Inflation Reduction Act.